October 4, 2017
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
|Re:||Can-Fite BioPharma Ltd.|
Registration Statement on Form F-3
File No. 333-220644
Ladies and Gentlemen:
Can-Fite BioPharma Ltd. (the “Company”) hereby withdraws its acceleration request letter dated October 2, 2017, which requested that the effective date of the Registration Statement on Form F-3 referenced above be accelerated so that it would have become effective at 4.00pm ET on October 4, 2017.
Very truly yours,
CAN-FITE BIOPHARMA LTD.
|By:||/s/ Pnina Fishman, Ph.D.|
|Name: Pnina Fishman, Ph.D.|
Title: Chief Executive Officer
cc: Gary Emmanuel (McDermott Will & Emery LLP)